Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 20 of 25
Effect of Thiazolidinediones on Human Bone
NCT00927355
Comparison Study of Breast Tomosynthesis Slice Thicknesses
NCT00957567
Digital Ocular Fundus Photography in the Emergency Department: A New Application for Telemedicine?
NCT00873613
Adverse Effects of RBC Transfusions: A Unifying Hypothesis
NCT00838331
Adverse Effects of Red Blood Cell Transfusions: A Unifying Hypothesis (Aim 3)
NCT02280655
Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores
NCT00832338
An Electronic Personal Health Record for Mental Health Consumers
NCT01724125
TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis
NCT01556282
Study of Possible Brain Hormone Problems After Open Heart Surgery in Infants
NCT00850720
Bedside Ultrasound Identifies Congestive Heart Failure
NCT00833144
Sickle Cell Disease Conditioning for Bone Marrow Transplant
NCT00968162
Vitamin D and Arteriovenous Fistulae
NCT00912782
Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI)
NCT00796419
Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
NCT00790478
A Study of Infliximab for Treatment Resistant Major Depression
NCT00463580
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
NCT00672854
Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease
NCT00790543
Prospective Liver Study
NCT01539993
Effects of Vitamin D Supplementation on Lung Function in an Acute Pulmonary Exacerbation of Cystic Fibrosis
NCT00788138
IMARA, Adapting SiHLE for Detained African American Adolescent Females
NCT00746369
Nutritional and Neurotransmitter Changes in PKU Subjects on BH4
NCT00688844
A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer
NCT00674206
Emory Latino Diabetes Education Program
NCT00793884
Insulin Delivery Using Microneedles in Type 1 Diabetes
NCT00837512
Hand Transplantation for the Reconstruction of Below the Elbow Amputations
NCT00778856
Surgical Treatment for Acute Patella Tendon Rupture
NCT00716508
Diabetes in the Perioperative Period
NCT00738114
Phenytoin and Multidose Activated Charcoal
NCT00823264
Stimulus Intensity in Left Ventricular Leads
NCT01060449
Interactive Study to Increase Glaucoma Adherence to Treatment
NCT00794170
Managing Epilepsy Well- WebEase Project
NCT00726076
Kaletra-isentress Treatment Evaluation
NCT00700115
Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers
NCT02185729
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
NCT00576797
Human Immune Responses to Yellow Fever Vaccination
NCT00694655
Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)
NCT00503750
Biological Basis of Individual Variation in Social Cooperation
NCT01566539
Examining the Effectiveness of an Early Psychological Intervention to Prevent Post-Traumatic Stress Disorder
NCT00895518
A Randomized Study of the Site for Growth Factor Injection for Patients Undergoing Autologous Stem Cell Transplantation
NCT00646763
Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients
NCT00646282
Biomarkers for Detection of Brain Ischemia
NCT00490295
Kidney Transplantation in Patients With Sickle Cell Disease
NCT00663507
A Phase I/II Trial of VR-CHOP in Lymphoma Patients
NCT00634179
A Phase I Trial of Bortezomib and Sunitinib
NCT00720148
A Comparison of Redrubber Versus Penrose Drains
NCT00645957
Low-dose Epinephrine Infusion Tests in Adolescent and Pediatric Patients
NCT00548886
Use of an Insulin Infusion Conversion Equation (IICE) to Control Blood Glucose in Hospitalized Patients
NCT00645827
Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid
NCT00166192
Investigation of the Athero-Protective Effects of Clopidogrel
NCT01283282
Congenital Heart Disease Research Registry
NCT00757510
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Emory University pipeline card: 1,208 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.